Analysis of 57,148 Transmissions by Remote Monitoring of Implantable Cardioverter Defibrillators
暂无分享,去创建一个
[1] Thomas Kleemann,et al. Annual Rate of Transvenous Defibrillation Lead Defects in Implantable Cardioverter-Defibrillators Over a Period of >10 Years , 2007, Circulation.
[2] L. Jordaens,et al. The role of remote monitoring in the reduction of inappropriate implantable cardioverter defibrillator therapies , 2006, Clinical Research in Cardiology.
[3] W. Grimm,et al. Complications of Implantable Cardioverter Defibrillator Therapy in 440 Consecutive Patients , 2005, Pacing and clinical electrophysiology : PACE.
[4] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[5] D. Weiss,et al. Remote Monitoring of Implantable Cardioverter Defibrillators: , 2004, Pacing and clinical electrophysiology : PACE.
[6] D. Theuns,et al. Home monitoring in ICD therapy: future perspectives. , 2003, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[7] J. Oss,et al. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .
[8] D. Mehta,et al. Late Complications in Patients with Pectoral Defibrillator Implants with Transvenous Defibrillator Lead Systems: High Incidence of Insulation Breakdown , 1998, Pacing and clinical electrophysiology : PACE.
[9] B. Wilkoff,et al. Lead- and device-related complications in the antiarrhythmics versus implantable defibrillators trial. , 2001, American heart journal.